产品信息
- Genetically modified cell lines best reflect MOA (Mechanism of Action)
- Higher activity and larger assay window for robust and reproducible cell-based bioassay
- Comprehensive application data to support assay development and validation
- Full tracible record, stringent quality control and validated cell passage stability
- Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
- Global commercial license assistance whenever regulatory filing is required
描述(Description)
The HEK293/Human ASGR1&ASGR2 Stable Cell Line was engineered to express the receptors full length human ASGR1 (Gene ID: 432) and ASGR2 (Gene ID: 433). Surface expression of human ASGR1 and ASGR2 was confirmed by flow cytometry.
应用说明(Application)
• Useful for cell-based ASGR1 or ASGR2 binding assay
生长特性(Growth Properties)
Adherent
筛选标记(Selection Marker)
Puromycin (2 μg/mL) + Hygromycin (10 μg/mL)
培养基(Complete Growth Medium)
DMEM + 10% FBS
冻存液(Freeze Medium)
Serum-free cell cryopreservation medium
装量(Quantity)
1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
存储(Storage)
Frozen in liquid nitrogen.
支原体检测(Mycoplasma Testing)
Negative
无菌检测(Sterility Testing)
Negative
使用说明(Instructions for Use)
See data sheet for detailed culturing and assay protocol.
产品数据图
Receptor Assay

Co-expression analysis of human ASGR1 and ASGR2 on HEK293/Human ASGR1&ASGR2 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human ASGR1&ASGR2 Stable Cell Line or negative control cell using APC-labeled anti-ASGR1 antibody and PE-labeled anti-ASGR2 antibody.
Protocol
产品评论 发表评论

背景
ASGPR, a transmembrane C-type lectin, recognizes a wide variety of ligands that contain either terminal galactose (Gal) or N-acetylgalactosamine (GalNAc) residues and has been identified as a highly selective receptor on hepatocytes. The ASGR is composed of both a major (ASGR1) and minor subunit (ASGR2).